Dr Girish Pai K
Associate Professor
Date of Joining : 11.08.2010
Department of Pharmaceutics
CURRENT ACADEMIC ROLE & RESPONSIBILITIES
- is the Coordinator - Centre for cGMP
- is responsible for establishing contacts with pharmaceutical companies as industry tie up.Is involved in planning and applying research projects with funding agencies like AICTE and DST etc.
- Maintains pilot laboratory.
- Is Subject Coordinator for Advanced Industrial Pharmacy PG course.
Dr Girish Pai Kis Associate Professor in the Department of Pharmaceutics.?
He:
SUBJECTS CURRENTLY TEACHING
| Subject | Semester / Year |
|---|---|
| Industrial Pharmacy I (Theory) | BPharm Sem-V |
| Industrial Pharmacy I (Practical) | BPharm Sem-V |
| Cosmetic Science (Theory) | BPharm Sem-VIII |
| Pharmaceutical Formulation Development | MPharm Industrial Pharmacy Sem-I |
| Industrial Pharmacy Practical I | MPharm Industrial Pharmacy Sem-I |
| Scale-up and Technology Transfer | MPharm Industrial Pharmacy Sem-II |
| Industrial Pharmacy Practical II | MPharm Industrial Pharmacy Sem-II |
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| PhD | Pharmaceutics | 365体育投注 Academy of Higher Education | 2015 |
| MPharm | Pharmaceutics | Rajiv Gandhi University of Health Sciences, Bangalore | 2000 |
| Computer Concepts, Windows 95, MS Excel, Internet and MS-Word | 365体育投注 Institute of Computer Education, Udupi | 1998 | |
| BPharm | Mangalore University | 1997 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| Department of Pharmaceutics | Assistant Professor - Senior Scale | 2013 | |
| Department of Pharmaceutics | Senior Grade Lecturer | 2010 to 31/12/2012 |
Development of a specialization wise digital OPD Platform and Validation of Drug Formulary
2016-26-09
Dr Girish Pai K facilitated the collaboration with Nerve24 Technologies Private Limited, Mumbai for various short and long-term research projects. MCOPS and Nerve24 signed MoU on September 26th 2016 for PhD scheme for research project Jointly under the Department of Pharmaceutics and Department of Pharmacy Practice.
Moderator to review papers
Served as a moderator to review papers for the 69th Indian Pharmaceutical Congress held at Chitkara Univeristy, Rajpura from 22nd to 24th December 2017
Poster Evaluation Chairman
Served as a Poster Chairman for the evaluation of scientific posters during 69th Indian Pharmaceutical Congress held at Chitkara Univeristy, Rajpura from 22nd to 24th December 2017
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Teaching, 365体育投注 and Industry Institute Tie-ups.
Area of Expertise
Plant Operations, Advanced Industrial Pharmacy, Validation Concepts, Stability Studies of Drug Products etc.
Area of 365体育投注
Formulation and Development of Ophthalmic inserts and improvement of existing conventional dosage forms.
Professional Affiliations & Contributions
- Life Member of Association of Pharmaceutical Teachers of India, 2010.
- Life Member of Drug delivery association, 2011.
- Life Member of Registered Pharmacist Karnataka State Pharmacy Council, 2008.
- Life Member of Fellow of the Academy of General Education, 2000.
Work Experience
| Organisation | Role | Tenure |
|---|---|---|
| Astra Zeneca Pharma India Pvt Ltd, Bangalore | Manager - Quality Assurance & Technical Services. Compliance to GMP, cGMP and QA Systems. | |
| Orchid Healthcare, Chennai | Deputy Manager - Quality Assurance. Site QA head for regulated & semi-regulated markets. | |
| Neopharma, UAE | Sr Executive & Incharge Quality Assurance. Validation of new facility & manufacturing assurance. | |
| CFL Pharma, Goa | Management Executive Trainee Role. Formulation Scientist |
Full publication list can be viewed at?
https://manipal.pure.elsevier.com/en/persons/girish-k-pai
https://eprints.manipal.edu/view/creators/Pai=3AGirish_K=3A=3A.html
Significance of reconstitution time and other physical parameters for evaluation of dry powder injectables
Girish Pai K Vamshi krishna T Shaila lewis Usha sree M
Int J Pharm Pharm Sci. 5 (3), 612-614 (2013).
Comparative evaluation of cephalosporin injectable product manufactured by generic and innovator company
Girish Pai K Krishna VT Kumar L Anup N Naveen D Reddy SM
Int J Pharm Res Sch. ISSN No: 2277-7873 I-1 (2013)
Comparative evaluation of the physical parameters of uncoated tablets of amlodipine besylate with different types of primary packaging materials
Girish Pai K Vamshi Krishna T Lalit Kumar M Sreenivasa Reddy G Shreenidhi A Praneeth Reddy
Asian J Pharm Res. 3 (1), 03-05 (2013).
Physical evaluation of the uncoated tablets of glimepiride with different types of primary packaging
Girish Pai K Vamshi Krishna T M Sreenivasa Reddy YSS Kishan V Aditya G Bhanuprakash M Vishnu Datta
365体育投注 J Pharm and Tech. 5(3) 404-407, (2012).
Formulation and evaluation of fixed dose combination products of rifampicin and isoniazid with improved rifampicin stability
Vamshi Krishna T Girish Pai K Naveen D M Sreenivasa Reddy
Int J Pharm Pharm Sci. 5 (3), 431-433 (2013).
A validated stability indicating HPLC method for determination of meropenem in active pharmaceutical ingredient and sterile pharmaceutical dosage form
Krishna BSM Vasantharaju SG Girish Pai K Spandana
Int J Multidisciplinary Res. 2 (6(III)), 25-29 (2013).
Invitro antidiabetic activity of pentacyclic Tritrpenoids and fatty acid esters from bauhinia purpurea
Gupta Daksha Kondongala Subraya Chandrashekar Girish Pai K
Int J Pharmacol Pharmaceut Tech. 2(1), 25-28 (2013).
Formulation and evaluation of extended release ocular inserts prepared from synthetic and natural biodegradable - biocompatible polymers
Girish Pai K Sreenivasa Reddy M
365体育投注 J Pharm Tech. 7 (1), 48-51 (2014).
Process deviations in pharmaceutical industry: Various types, handling procedure and systems
Vamshi Krishna T Lalit Kumar Sreenivasa Reddy Girish Pai K
365体育投注 J Pharm Tech. 7(3), 340-342 (2014).
Solubility enhancement of Norfloxacin by hydrotropy technique
Girish pai K Divya S M Sreenivasa reddy Lalit Kumar Vamshi Krishna T
Int J Pharm PharmSci. 6(8), 395-397 (2014).
Investigation to find out the root cause for presence of broken tablet in the marketed blister pack
Vamshi Krishna T Lalit Kumar M Sreenivasa Reddy Rajat Rao M Ankineedu Girish Pai K
365体育投注 J Pharm Tech. 8(6), 707-709 (2015).
Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles
Lalit Kumar M Sreeenivasa Reddy Renuka S Managuli Girish Pai K
Saudi Pharm J. 23, 549-555 (2015).
Enteric coated capsules of eprosartan mesylate withpH-modifier for augmenting the dissolution
Damodaram Atmakuri Zenab Attari Koteshwara KB
Int. J. Res. Pharm. Sci. 2016, 7(1), 34-38.
Formulation And Evaluation of Decitabine Powder For Injection Using Lyophilization And Comparison With The Innovator
Vibha V
PG Project (2014)
Science and risk based approach for process validation and equipment qualification of a generic product
Ekta Prasanthi Bommireddy
PG Project (2015)
Utility System Validation: A Systematic Qualification Approach For Hvac, Water System & Compressed Air System In Hormonal Oral Solid Dosage Form Facility
Tajally Zia
PG Project (2015)
Formulation And Evaluation of Deferasirox Dispersible Tablets with Increase in Percentage Drug Release Compared to the Innovator Product
Sai Sirisha V B V
PG Project (2015)
Optimization of Compression Parameters of an Immediate Release Tablet Using the Concept of Quality By Design (QbD)
Rajat Rao
PG Project (2015)
Porous Solid Dosage Forms For Low Dose Drugs
G Sandeep Nahata
PG project (2016)
Porous Solid Dosage Forms For High Dose Drugs
Nandakumaran G
PG project (2016)
Association with Nerve24 as Honorary Advisor
Dr Girish Pai K is associated with Nerve24 Technologies Private Limited, Mumbai as ‘Honorary Advisor’ effective 12th December, 2016. Nerve24, a Healthcare service provider based in Mumbai, enables patient community or healthcare providers to engage with any other / each service provider through “innovative tech platform"
Appointment as Visiting Professor at Pharma Training Institute, Bengaluru
Dr Girish Pai K, faculty from Department of Pharmaceutics, MCOPS, is appointed as Visiting Professor at Pharma Training Institute (PTI), Bengaluru. PTI, under the aegis of the Karnataka Pharmaceutical Trust & first of its kind, was formed and registered in 1993. Former Drug Controller of Karnataka and Principal of Government College of Pharmacy, Professor V.B.Desai is the Chairman of the Trust and other Trustees include 5 Leading Industrialists from Bangalore and another Former Drug Controller of Karnataka State. Pharma Training Institute, popularly known as PTI, was established in 2008 with the main aim of fulfilling the long pending desire to bridge the gap between Academia and Industry. Dr Pai is the only faculty from academics & rest of the faculties are former officials from Drugs control department, Karnataka, and Technical heads from reputed pharmaceutical companies.